{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:38:20Z","timestamp":1777480700743,"version":"3.51.4"},"reference-count":56,"publisher":"Zhejiang University Press","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401167"],"award-info":[{"award-number":["81401167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Zhejiang Province Science Foundation for Distinguished Young Scholars","award":["LR16H040001"],"award-info":[{"award-number":["LR16H040001"]}]},{"name":"the Medical and Health General Project of Zhejiang Province, China","award":["2015KYA122"],"award-info":[{"award-number":["2015KYA122"]}]},{"name":"the Zhejiang Traditional Chinese Medicine Foundation , China","award":["2017ZQ020"],"award-info":[{"award-number":["2017ZQ020"]}]},{"name":"the Zhejiang Traditional Chinese Medicine Foundation , China","award":["2017ZA091"],"award-info":[{"award-number":["2017ZA091"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1631\/jzus.b1700074","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T08:59:41Z","timestamp":1526288381000},"page":"354-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["American, European, and Chinese practice guidelines or consensuses of polycystic ovary syndrome: a comparative analysis","\u5173\u4e8e\u7f8e\u56fd\u3001\u6b27\u6d32\u548c\u4e2d\u56fd\u7684\u591a\u56ca\u5375\u5de2\u7efc\u5408\u5f81\u4e34\u5e8a\u6307 \u5357\u6216\u5171\u8bc6\u7684\u6bd4\u8f83\u5206\u6790"],"prefix":"10.1631","volume":"19","author":[{"given":"Fang-fang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-xue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-hang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Hardiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1851-1514","authenticated-orcid":false,"given":"Fan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"issue":"2","key":"4_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jpag.2014.05.005","volume":"28","author":"N Amr","year":"2015","unstructured":"Amr N, Abdel-Rahim HE, 2015. The effect of chromium supplementation on polycystic ovary syndrome in adolescents. J Pediatr Adolesc Gynecol, 28(2):114\u2013118. https:\/\/doi.org\/10.1016\/j.jpag.2014.05.005","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"4_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/humrep\/der396","volume":"27","author":"The Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","year":"2012","unstructured":"The Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group, 2012. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS). Hum Reprod, 27(1):14\u201324. https:\/\/doi.org\/10.1093\/humrep\/der396","journal-title":"Hum Reprod"},{"key":"4_CR3","volume-title":"Hyperandrogenism during Puberty and Adolescence, and Its Relationship to Reproductive Function in the Adult Female","author":"D Apter","year":"1993","unstructured":"Apter D, Butzow T, Laughlin G, 1993. Hyperandrogenism during Puberty and Adolescence, and Its Relationship to Reproductive Function in the Adult Female. Raven Press, p.265."},{"issue":"3","key":"4_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/jog.12907","volume":"42","author":"S Ashoush","year":"2016","unstructured":"Ashoush S, Abou-Gamrah A, Bayoumy H, et al., 2016. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: randomized controlled trial. J Obstet Gynaecol Res, 42(3):279\u2013285. https:\/\/doi.org\/10.1111\/jog.12907","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"4_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/gye.15.3.170.177","volume":"15","author":"CK Avvad","year":"2001","unstructured":"Avvad CK, Holeuwerger R, Silva VC, et al., 2001. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence. Gynecol Endocrinol, 15(3):170\u2013177. https:\/\/doi.org\/10.1080\/713602836","journal-title":"Gynecol Endocrinol"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1477-7525-11-141","volume":"11","author":"F Bazarganipour","year":"2013","unstructured":"Bazarganipour F, Ziaei S, Montazeri A, et al., 2013. Psychological investigation in patients with polycystic ovary syndrome. Health Qual Life Out, 11:141. https:\/\/doi.org\/10.1186\/1477-7525-11-141","journal-title":"Health Qual Life Out"},{"issue":"6","key":"4_CR7","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","volume":"167","author":"E Carmina","year":"1992","unstructured":"Carmina E, Koyama T, Chang L, et al., 1992. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol, 167(6):1807\u20131812. https:\/\/doi.org\/10.1016\/0002-9378(92)91779-A","journal-title":"Am J Obstet Gynecol"},{"key":"4_CR8","first-page":"1","volume":"330","author":"ZJ Chen","year":"2011","unstructured":"Chen ZJ, Zhang YW, Liu JY, et al., 2011. Diagnosis criteria for polycystic ovary syndrome. Natl Health Fam Plan Commission China, 330:1\u20137 (in Chinese).","journal-title":"Natl Health Fam Plan Commission China"},{"issue":"4","key":"4_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1210\/jc.2007-2429","volume":"93","author":"M Cosma","year":"2008","unstructured":"Cosma M, Swiglo BA, Flynn DN, et al., 2008. Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab, 93(4):1135\u20131142. https:\/\/doi.org\/10.1210\/jc.2007-2429","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/humrep\/des424","volume":"28","author":"LL Cui","year":"2013","unstructured":"Cui LL, Zhao H, Zhang B, et al., 2013. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women. Hum Reprod, 28(2):538\u2013544. https:\/\/doi.org\/10.1093\/humrep\/des424","journal-title":"Hum Reprod"},{"issue":"10","key":"4_CR11","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","volume":"41","author":"A Dunaif","year":"1992","unstructured":"Dunaif A, Segal KR, Shelley DR, et al., 1992. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes, 41(10):1257\u20131266. https:\/\/doi.org\/10.2337\/diabetes.41.10.1257","journal-title":"Diabetes"},{"issue":"1","key":"4_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2337\/diacare.22.1.141","volume":"22","author":"DA Ehrmann","year":"1999","unstructured":"Ehrmann DA, Barnes RB, Rosenfield RL, et al., 1999. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabet Care, 22(1):141\u2013146. https:\/\/doi.org\/10.2337\/diacare.22.1.141","journal-title":"Diabet Care"},{"issue":"7","key":"4_CR13","first-page":"553","volume":"43","author":"Endocrinology Group, ObstetricsGynecology Committee, China Medical Association","year":"2008","unstructured":"Endocrinology Group, Obstetrics and Gynecology Committee, China Medical Association, 2008. Consensus on the diagnosis and treatment for polycystic ovary syndrome. Chin J Obstet Gynecol, 43(7):553\u2013555 (in Chinese).","journal-title":"Chin J Obstet Gynecol"},{"issue":"1","key":"4_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, et al., 2012. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril, 97(1): 28\u201338. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.09.024","journal-title":"Fertil Steril"},{"issue":"04","key":"4_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-0035-1548790","volume":"123","author":"F Foroozanfard","year":"2015","unstructured":"Foroozanfard F, Jamilian M, Jafari Z, et al., 2015. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabet, 123(04):215\u2013220. https:\/\/doi.org\/10.1055\/s-0035-1548790","journal-title":"Exp Clin Endocrinol Diabet"},{"issue":"3","key":"4_CR16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.appet.2007.03.222","volume":"49","author":"C Galletly","year":"2007","unstructured":"Galletly C, Moran L, Noakes M, et al., 2007. Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome\u2014a pilot study. Appetite, 49(3):590\u2013593. https:\/\/doi.org\/10.1016\/j.appet.2007.03.222","journal-title":"Appetite"},{"issue":"2","key":"4_CR17","first-page":"93","volume":"13","author":"A Ghaneei","year":"2015","unstructured":"Ghaneei A, Jowkar A, Ghavam MRH, et al., 2015. Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia. Iran J Reprod Med, 13(2):93\u2013100.","journal-title":"Iran^J Reprod Med"},{"issue":"6","key":"4_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0015-0282(16)35047-6","volume":"14","author":"JW Goldzieher","year":"1963","unstructured":"Goldzieher JW, Axelrod LR, 1963. Clinical and biochemical features of polycystic ovarian disease. Fertil Steril, 14(6): 631\u2013653. https:\/\/doi.org\/10.1016\/S0015-0282(16)35047-6","journal-title":"Fertil Steril"},{"issue":"9","key":"4_CR19","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1210\/jc.2003-030424","volume":"88","author":"L Harborne","year":"2003","unstructured":"Harborne L, Fleming R, Lyall H, et al., 2003. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab, 88(9):4116\u20134123. https:\/\/doi.org\/10.1210\/jc.2003-030424","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/humupd\/dmq045","volume":"17","author":"CL Harrison","year":"2011","unstructured":"Harrison CL, Lombard CB, Moran LJ, et al., 2011. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update, 17(2):171\u2013183. https:\/\/doi.org\/10.1093\/humupd\/dmq045","journal-title":"Hum Reprod Update"},{"issue":"4","key":"4_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/jwh.2014.5000","volume":"24","author":"AE Joham","year":"2015","unstructured":"Joham AE, Teede HJ, Ranasinha S, et al., 2015. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large communitybased cohort study. J Womens Health, 24(4):299\u2013307. https:\/\/doi.org\/10.1089\/jwh.2014.5000","journal-title":"J Womens Health"},{"issue":"1","key":"4_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1210\/jc.2003-030932","volume":"89","author":"JS Laven","year":"2004","unstructured":"Laven JS, Mulders AGMGJ, Visser JA, et al., 2004. Antimullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab, 89(1):318\u2013323. https:\/\/doi.org\/10.1210\/jc.2003-030932","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4_CR23","first-page":"165","volume":"84","author":"RS Legro","year":"1999","unstructured":"Legro RS, Kunselman AR, Dodson WC, et al., 1999. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab, 84(1):165\u2013169. https:\/\/doi.org\/10.1210\/jcem.84.1.5393","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"4_CR24","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, et al., 2013. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 98(12):4565\u20134592. https:\/\/doi.org\/10.1210\/jc.2013-2350","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1056\/NEJMoa1313517","volume":"371","author":"RS Legro","year":"2014","unstructured":"Legro RS, Brzyski RG, Diamond MP, et al., 2014. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med, 371(2):119\u2013129. https:\/\/doi.org\/10.1056\/NEJMoa1313517","journal-title":"N Engl^J Med"},{"issue":"9","key":"4_CR26","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/humrep\/det262","volume":"28","author":"R Li","year":"2013","unstructured":"Li R, Zhang Q, Yang D, et al., 2013. Prevalence of polycystic ovary syndrome in women in China: a large communitybased study. Hum Reprod, 28(9):2562\u20132569. https:\/\/doi.org\/10.1093\/humrep\/det262","journal-title":"Hum Reprod"},{"issue":"4","key":"4_CR27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/0002-9378(83)90324-1","volume":"145","author":"RA Lobo","year":"1983","unstructured":"Lobo RA, Granger LR, Paul WL, et al., 1983. Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. Am J Obstet Gynecol, 145(4): 496\u2013503. https:\/\/doi.org\/10.1016\/0002-9378(83)90324-1","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"4_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/EJE-15-0646","volume":"173","author":"M Luque-Ramirez","year":"2015","unstructured":"Luque-Ramirez M, Alpanes M, Sanchon R, et al., 2015. Referral bias in female functional hyperandrogenism and polycystic ovary syndrome. Eur J Endocrinol, 173(5): 603\u2013610. https:\/\/doi.org\/10.1530\/EJE-15-0646","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"4_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11414-013-9382-7","volume":"42","author":"JG McCook","year":"2015","unstructured":"McCook JG, Bailey BA, Williams SL, et al., 2015. Differential contributions of polycystic ovary syndrome (PCOS) manifestations to psychological symptoms. J Behav Health Serv Res, 42(3):383\u2013394. https:\/\/doi.org\/10.1007\/s11414-013-9382-7","journal-title":"J Behav Health Serv Res"},{"issue":"11","key":"4_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.6061\/clinics\/2015(11)09","volume":"70","author":"AS Melo","year":"2015","unstructured":"Melo AS, Ferriani RA, Navarro PA, 2015. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics, 70(11):765\u2013769. https:\/\/doi.org\/10.6061\/clinics\/2015(11)09","journal-title":"Clinics"},{"issue":"1","key":"4_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.fertnstert.2016.05.011","volume":"106","author":"SS Merkin","year":"2016","unstructured":"Merkin SS, Phy JL, Sites CK, et al., 2016. Environmental determinants of polycystic ovary syndrome. Fertil Steril, 106(1):16\u201324. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.011","journal-title":"Fertil Steril"},{"issue":"5","key":"4_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.5603\/EP.2013.0025","volume":"64","author":"A Milewicz","year":"2013","unstructured":"Milewicz A, 2013. Reimbursement of metformin for polycystic ovary syndrome. Endokrynol Pol, 64(5):409\u2013414. https:\/\/doi.org\/10.5603\/EP.2013.0025","journal-title":"Endokrynol Pol"},{"issue":"3","key":"4_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0022-3476(83)80678-7","volume":"102","author":"GW Moll","year":"1983","unstructured":"Moll GW, Rosenfield RL, 1983. Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J Pediatr, 102(3):461\u2013464. https:\/\/doi.org\/10.1016\/S0022-3476(83)80678-7","journal-title":"J Pediatr"},{"key":"4_CR34","volume-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"LJ Moran","year":"2011","unstructured":"Moran LJ, Hutchison SK, Norman RJ, et al., 2011. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev, 7: CD007506. https:\/\/doi.org\/10.1002\/14651858.CD007506.pub3"},{"issue":"5","key":"4_CR35","first-page":"457","volume":"67","author":"G Morgante","year":"2015","unstructured":"Morgante G, Cappelli V, di Sabatino A, et al., 2015. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association. Minerva Ginecol, 67(5): 457\u2013463.","journal-title":"Minerva Ginecol"},{"issue":"10","key":"4_CR36","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.sleep.2012.07.002","volume":"13","author":"K Nandalike","year":"2012","unstructured":"Nandalike K, Agarwal C, Strauss T, et al., 2012. Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome. Sleep Med, 13(10):1307\u20131312. https:\/\/doi.org\/10.1016\/j.sleep.2012.07.002","journal-title":"Sleep Med"},{"issue":"1","key":"4_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijgo.2012.01.027","volume":"118","author":"R Nidhi","year":"2012","unstructured":"Nidhi R, Padmalatha V, Nagarathna R, et al., 2012. Effect of a yoga program on glucose metabolism and blood lipid levels in adolescent girls with polycystic ovary syndrome. Int J Gynaecol Obstet, 118(1):37\u201341. https:\/\/doi.org\/10.1016\/j.ijgo.2012.01.027","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"4_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0015-0282(16)57297-5","volume":"63","author":"RJ Norman","year":"1995","unstructured":"Norman RJ, Mahabeer S, Masters S, 1995. Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. Fertil Steril, 63(1):58\u201362. https:\/\/doi.org\/10.1016\/S0015-0282(16)57297-5","journal-title":"Fertil Steril"},{"issue":"9588","key":"4_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, et al., 2007. Polycystic ovary syndrome. Lancet, 370(9588):685\u2013697. https:\/\/doi.org\/10.1016\/S0140-6736(07)61345-2","journal-title":"Lancet"},{"issue":"6","key":"4_CR40","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3109\/09513590.2013.788634","volume":"29","author":"CT Pau","year":"2013","unstructured":"Pau CT, Keefe CC, Welt CK, 2013. Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome. Gynecol Endocrinol, 29(6):551\u2013555. https:\/\/doi.org\/10.3109\/09513590.2013.788634","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"4_CR41","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1210\/jc.2005-2076","volume":"91","author":"P Pigny","year":"2006","unstructured":"Pigny P, Jonard S, Robert Y, et al., 2006. Serum anti-mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab, 91(3):941\u2013945. https:\/\/doi.org\/10.1210\/jc.2005-2076","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1631\/jzus.B1600437","volume":"18","author":"F Qu","year":"2017","unstructured":"Qu F, Li R, Sun W, et al., 2017. Use of electroacupuncture and transcutaneous electrical acupoint stimulation in reproductive medicine: a group consensus. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 18(3):186\u2013193. https:\/\/doi.org\/10.1631\/jzus.B1600437","journal-title":"J Zhejiang Univ-Sci^B (Biomed & Biotechnol)"},{"issue":"5","key":"4_CR43","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0002-9378(99)70120-1","volume":"181","author":"R Rivera","year":"1999","unstructured":"Rivera R, Yacobson I, Grimes D, 1999. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol, 181(5):1263\u20131269. https:\/\/doi.org\/10.1016\/S0002-9378(99)70120-1","journal-title":"Am^J Obstet Gynecol"},{"issue":"2","key":"4_CR44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1558\/cam.v9i2.125","volume":"9","author":"KK Roessler","year":"2012","unstructured":"Roessler KK, Glintborg D, Ravn P, et al., 2012. Supportive relationships\u2014psychological effects of group counselling in women with polycystic ovary syndrome (PCOS). Commun Med, 9(2):125\u2013131.","journal-title":"Commun Med"},{"issue":"4","key":"4_CR45","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1210\/jc.2014-4290","volume":"100","author":"RL Rosenfield","year":"2015","unstructured":"Rosenfield RL, Ehrmann DA, Littlejohn EE, 2015. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood. J Clin Endocrinol Metab, 100(4):1537\u20131543. https:\/\/doi.org\/10.1210\/jc.2014-4290","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group, 2004a. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril, 81(1):19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"issue":"1","key":"4_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group, 2004b. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod, 19(1): 41\u201347. https:\/\/doi.org\/10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"issue":"6","key":"4_CR48","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/cen.13003","volume":"84","author":"M Samimi","year":"2016","unstructured":"Samimi M, Jamilian M, Ebrahimi FA, et al., 2016. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol, 84(6):851\u2013857. https:\/\/doi.org\/10.1111\/cen.13003","journal-title":"Clin Endocrinol"},{"issue":"3","key":"4_CR49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jpag.2013.09.015","volume":"27","author":"G Stabile","year":"2014","unstructured":"Stabile G, Borrielli I, Artenisio AC, et al., 2014. Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome. J Pediatr Adolesc Gynecol, 27(3):177\u2013182. https:\/\/doi.org\/10.1016\/j.jpag.2013.09.015","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"9","key":"4_CR50","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1093\/humrep\/den227","volume":"23","author":"S Tan","year":"2008","unstructured":"Tan S, Hahn S, Benson S, et al., 2008. Psychological implications of infertility in women with polycystic ovary syndrome. Hum Reprod, 23(9):2064\u20132071. https:\/\/doi.org\/10.1093\/humrep\/den227","journal-title":"Hum Reprod"},{"issue":"3","key":"4_CR51","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","volume":"89","author":"The Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","unstructured":"The Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group, 2008a. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril, 89(3):505\u2013522. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.09.041","journal-title":"Fertil Steril"},{"issue":"3","key":"4_CR52","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/humrep\/dem426","volume":"23","author":"The Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","unstructured":"The Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group, 2008b. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod, 23(3):462\u2013477. https:\/\/doi.org\/10.1093\/humrep\/dem426","journal-title":"Hum Reprod"},{"issue":"9","key":"4_CR53","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1471-0528.2009.02177.x","volume":"116","author":"RL Thomson","year":"2009","unstructured":"Thomson RL, Buckley JD, Moran LJ, et al., 2009. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. BJOG, 116(9):1242\u20131250. https:\/\/doi.org\/10.1111\/j.1471-0528.2009.02177.x","journal-title":"BJOG"},{"issue":"15","key":"4_CR54","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1073\/pnas.1418216112","volume":"112","author":"F Wang","year":"2015","unstructured":"Wang F, Pan J, Liu Y, et al., 2015. Alternative splicing of the androgen receptor in polycystic ovary syndrome. Proc Natl Acad Sci USA, 112(15):4743\u20134748. https:\/\/doi.org\/10.1073\/pnas.1418216112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"4_CR55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1631\/jzus.B1500301","volume":"17","author":"Y Wu","year":"2016","unstructured":"Wu Y, Robinson N, Hardiman P, et al., 2016. Acupuncture for treating polycystic ovary syndrome: guidance for future randomized controlled trials. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 17(3):169\u2013180. https:\/\/doi.org\/10.1631\/jzus.B1500301","journal-title":"J Zhejiang Univ-Sci^B (Biomed & Biotechnol)"},{"issue":"4","key":"4_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000358485","volume":"77","author":"J Zhuang","year":"2014","unstructured":"Zhuang J, Liu Y, Xu L, et al., 2014. Prevalence of the polycystic ovary syndrome in female residents of Chengdu, China. Gynecol Obstet Invest, 77(4):217\u2013223. https:\/\/doi.org\/10.1159\/000358485","journal-title":"Gynecol Obstet Invest"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1631\/jzus.B1700074\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1700074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1700074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T23:10:31Z","timestamp":1604272231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1631\/jzus.B1700074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b1700074","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"12 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}